Browse diseases

…, particularly FIB-4 and GPR for identifying severe fibrosis in chronic hepatitis B. Among the two chatbots tested, ChatGPT-5 was closer to the ref…

…ted with HBsAg seroclearance in a large cohort of patients with chronic hepatitis B (CHB).1 The qHBsAg, as a key marker of chronic HBV infection, i…

… hepatitis B surface antigen (HBsAg) loss in some subjects with chronic hepatitis B (CHB), potentially revealing immune correlates of functional cu…

…rapeutic target and predictive biomarker for functional cure in chronic hepatitis B.Abstract IDDF2026-ABS-0371 Figure 1Abstract IDDF2026-ABS-0371 F…

…nctional validation constrained generalisability.Conclusions In CHB, scRNA-seq refines rather than transforms concepts of immune dy…

…earance is linked to substantially lower risks of cirrhosis and hepatocellular carcinoma, and it allows for safe discontinuation of NA therapy.1 The 202…

…e of HBV-ACLF, 6/5/6) and 15 control subjects (liver cirrhosis, chronic hepatitis B and healthy controls, 5/5/5). Functional and mechanistic experi…

… in order to reduce the risk of liver-related complications and hepatocellular carcinoma (HCC). The aim of this study is to assess the cost-effectivenes…

…s consistent with SCLE developed shortly after the diagnosis of Whipple’s disease, with extensive involvement of the trunk and limbs and marked p…

…ive care expenditure (CCE) from different comorbidity states of chronic hepatitis B (CHB), to provide a reference for the relevant government depar…

…ols. The area under the curve for differentiating patients with HBeAg-expressing CHB from healthy controls was 0.9701. Glycine supplementation dimin…

…e observed in patients with and without cirrhosis.Patients with CHD with and without cirrhosis who were treated with BLV 2 mg for u…